Residency · Residency · Chronic Pain Management

Chronic Low Back Pain: Evidence-Based Approach

Introduction

Chronic low back pain (CLBP) is defined as pain persisting beyond 12 weeks in the lumbosacral region. It affects approximately 20% of adults worldwide and is the leading cause of disability globally. An evidence-based approach requires systematic evaluation, risk stratification, and a stepped-care model that integrates pharmacologic, rehabilitative, psychological, and interventional strategies tailored to the individual patient's pain phenotype.

Differential Diagnosis

A structured differential diagnosis is essential to avoid missed pathology and guide treatment. Mechanical and degenerative causes include lumbar spondylosis, degenerative disc disease, facet arthropathy, and sacroiliac joint dysfunction. Radiculopathy from disc herniation with nerve root compression or foraminal stenosis must be distinguished from axial pain. Spinal stenosis with neurogenic claudication represents central canal narrowing. Myofascial pain from quadratus lumborum, multifidus, and piriformis trigger points is common and frequently overlooked. Sacroiliac joint pain is estimated to account for 15-30% of axial low back pain. Vertebral compression fractures should be considered, particularly in osteoporotic or oncologic populations. Red flags demanding urgent workup include cauda equina syndrome (saddle anesthesia, urinary retention), progressive motor deficit, fever with spinal tenderness, unexplained weight loss, and history of malignancy.

Diagnostic Evaluation

The history should capture onset, duration, aggravating and alleviating factors, radicular symptoms, and psychosocial screening using a tool like the STarT Back Tool. Physical examination includes lumbar range of motion, straight leg raise, femoral nerve stretch test, neurologic examination, and provocative sacroiliac joint maneuvers (the cluster of Laslett). Regarding imaging, the ACP and ACR Appropriateness Criteria recommend against routine imaging in the absence of red flags. When imaging is indicated, MRI is the modality of choice. Plain radiographs may be appropriate for evaluating alignment, instability, or fracture.

<image>Annotated sagittal MRI of the lumbar spine demonstrating degenerative disc disease at L4-L5 and L5-S1 with disc desiccation, posterior disc bulge, and mild central canal stenosis, with labeled anatomical landmarks including vertebral bodies, intervertebral discs, thecal sac, and cauda equina</image>

Pharmacotherapy

Pharmacologic management should follow a rational, stepwise approach guided by current guidelines (ACP 2017, NICE 2020). First-line agents include NSAIDs (naproxen 500 mg twice daily, ibuprofen 600 mg three times daily) with gastroprotective agents as needed, and duloxetine 60 mg daily (NNT approximately 7 for 30% pain reduction). Second-line options include tramadol for short-term flares and tricyclic antidepressants (amitriptyline 10-75 mg nightly) for neuropathic components. Cyclobenzaprine at 5-10 mg nightly can help with acute-on-chronic exacerbations but should be limited to 2-3 weeks. Topical agents such as diclofenac gel and lidocaine patches are useful for localized pain. Opioids are reserved for refractory cases after failure of non-opioid therapies, with structured risk assessment (ORT, DIRE), treatment agreements, and urine drug monitoring. Gabapentinoids for non-radicular CLBP show poor efficacy, and acetaminophen monotherapy is not recommended based on the PACE trial data.

Physical Therapy and Rehabilitation

Motor control exercises targeting multifidus and transversus abdominis reactivation have strong evidence for reducing pain and disability. Graded exercise therapy with progressive aerobic conditioning — walking, swimming, cycling — improves functional capacity and pain self-efficacy. The McKenzie method (mechanical diagnosis and therapy) uses directional preference assessment to guide repeated end-range movements. Yoga and Pilates have moderate evidence supporting clinically meaningful improvements in pain and function at 12 weeks. Spinal manipulation provides short-term benefit for acute and subacute presentations and is guideline-recommended as an adjunct.

<image>Medical illustration showing a cross-sectional view of the lumbar spine at L4-L5 level with labeled deep stabilizing muscles including multifidus, transversus abdominis, and erector spinae, with arrows demonstrating the motor control exercise activation pattern for core stabilization rehabilitation</image>

Cognitive Behavioral Therapy

Cognitive behavioral therapy is the most extensively studied psychological intervention for CLBP, with moderate-quality evidence supporting clinically significant improvements in pain intensity, disability, and catastrophizing. It addresses pain catastrophizing, fear-avoidance beliefs, and maladaptive coping through techniques including cognitive restructuring, behavioral activation, graded exposure to feared movements, and relaxation training. Treatment is typically delivered in 8-12 sessions and can be integrated into interdisciplinary pain rehabilitation programs. Combining pain neuroscience education (PNE) with CBT enhances outcomes by helping patients reconceptualize pain as a modifiable central nervous system process rather than a fixed reflection of tissue damage.

Stepped-Care Interventional Management

When conservative measures fail — typically after 6-12 weeks of active participation — interventional options are considered based on the identified pain generator. Epidural steroid injections are indicated for radiculopathy or radicular pain, with the transforaminal approach offering target specificity; evidence supports short-to-intermediate term relief. For confirmed facet-mediated pain, medial branch blocks followed by radiofrequency ablation are the standard approach. Dual diagnostic blocks with at least 80% concordant relief should precede RFA, which provides 6-12 months of relief. Sacroiliac joint interventions begin with intra-articular injections for diagnostic confirmation, followed by lateral branch radiofrequency ablation (cooled or conventional) for durable relief. Trigger point injections with local anesthetic, with or without corticosteroid, address myofascial components. Spinal cord stimulation is considered for persistent radicular pain post-laminectomy (failed back surgery syndrome) or refractory CLBP, with NICE and NACC guidelines recommending an SCS trial after failure of conventional medical management.

<image>Fluoroscopic image demonstrating proper needle placement for a lumbar medial branch block at L4 and L5 levels, with labeled anatomical landmarks including the junction of the transverse process and superior articular process, with contrast spread pattern confirming correct position</image>

Clinical Pearls

Psychosocial yellow flags — fear-avoidance, catastrophizing, depression, work dissatisfaction — should always be screened for using validated tools such as the STarT Back Screening Tool, as they guide treatment intensity and predict outcomes. Early imaging in the absence of red flags should be avoided because incidental findings on MRI (disc bulges, facet hypertrophy) are highly prevalent in asymptomatic individuals and can drive unnecessary interventions. Multimodal therapy combining active physical therapy, psychological strategies, and rational pharmacotherapy yields superior outcomes compared to any single modality. Diagnostic blocks must precede ablative procedures because a single uncontrolled block has a false-positive rate of 25-40%. Setting realistic expectations is fundamental: the goal of chronic pain management is functional restoration and improved quality of life, not complete pain elimination.

References

1. Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):480-492.
2. Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-2383.
3. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736-747.
4. Cohen SP, Hooten WM. Advances in the diagnosis and management of neck pain. BMJ. 2017;358:j3221.

Read this lecture as Markdown